Clinical Trial Update: Losartan in Prevention of Radiation-Induced Heart Failure [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating losartan to prevent radiation-induced heart failure in patients with breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Myocardial Fibrosis
• Radiation-induced Fibrosis

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer, Myocardial Fibrosis | EARLY_Phase 1 | Status: COMPLETED